Felix Oden
9Patents
2h-index
14Co-inventors
40Inventor score
Filing activity: Nov 1, 2013 → Oct 23, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10189906B2 | Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases | Chemistry; Metallurgy | 6 | Active |
| US10144782B2 | Humanized antibodies against CD269 (BCMA) | Chemistry; Metallurgy | 6 | Active |
| US10835624B2 | Compounds for imaging Tau protein aggregates | Physics | 0 | Active |
| US10851172B2 | Humanized antibodies against CD269 (BCMA) | Chemistry; Metallurgy | 0 | Active |
| US10865207B2 | Compounds for imaging Tau protein aggregates | Physics | 0 | Active |
| US11820829B2 | Humanized antibodies against CD269 (BCMA) | Chemistry; Metallurgy | 0 | Active |
| US10745486B2 | Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US11667722B2 | Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US11306089B2 | Gamma-carboline compounds for the detection of Tau aggregates | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.